Publikationen, an denen er mitarbeitet JESUS MIGUEL UNDA URZAIZ (77)

2024

  1. Why is it necessary to produce a BCG strain in Spain?

    Actas Urologicas Espanolas

2023

  1. A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer

    Actas Urologicas Espanolas, Vol. 47, Núm. 2, pp. 111-126

  2. Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors’ reply

    Actas Urologicas Espanolas

  3. Hormone sensitive protocol for metastatic prostate cancer, an update

    Actas Urologicas Espanolas, Vol. 47, Núm. 4, pp. 244-249

  4. Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial

    European urology oncology, Vol. 6, Núm. 1, pp. 58-66

  5. Identifying prognostic parameters related to surgical technique in patients treated by robotic radical prostatectomy

    Actas Urologicas Espanolas, Vol. 47, Núm. 1, pp. 47-55

  6. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

  7. Using the Synergy between HPLC-MS and MALDI-MS Imaging to Explore the Lipidomics of Clear Cell Renal Cell Carcinoma

    Analytical Chemistry, Vol. 95, Núm. 4, pp. 2285-2293

2022

  1. Non-metastatic castration-resistant prostate cancer: management recommendations

    Actas Urologicas Espanolas, Vol. 46, Núm. 4, pp. 193-213

  2. PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer

    Oncogenesis, Vol. 11, Núm. 1

2021

  1. Clinical implications of (Pro)renin receptor (prr) expression in renal tumours

    Diagnostics, Vol. 11, Núm. 2

  2. Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma

    Cancers, Vol. 13, Núm. 4, pp. 1-17

2020

  1. 1H NMR-Based Urine Metabolomics Reveals Signs of Enhanced Carbon and Nitrogen Recycling in Prostate Cancer

    Journal of Proteome Research, Vol. 19, Núm. 6, pp. 2419-2428

  2. Perspectiva histórica del tratamiento sistémico del cáncer de vejiga músculo invasivo

    Archivos espanoles de urologia, Vol. 73, Núm. 10, pp. 954-960

  3. The urinary transcriptome as a source of biomarkers for prostate cancer

    Cancers, Vol. 12, Núm. 2

2019

  1. Safety of nivolumab in metastatic renal cell carcinoma patients: A real-life experience in a Spanish urology setting

    Actas Urologicas Espanolas, Vol. 43, Núm. 7, pp. 364-370

2018

  1. Actualización del papel de la quimioterapia endovesical en el cáncer de vejiga no músculo-invasivo

    Actas Urologicas Espanolas

  2. Consensus statement on definition, diagnosis, and management of high-risk prostate cancer patients on behalf of the Spanish Groups of Uro-Oncology Societies URONCOR, GUO, and SOGUG

    Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 392-401

  3. Future advances in the endovesical treatment of NMIBC

    Archivos Espanoles de Urologia

  4. Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer

    Cell Death and Disease, Vol. 9, Núm. 10